UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15 (d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): February 21, 2005
LYDALL, INC.
(Exact name of registrant as specified in its charter)
Commission file number: 1-7665
| Delaware | 06-0865505 | |
| (State or Other Jurisdiction of Incorporation or Organization) |
(I.R.S. Employer Identification No.) |
| One Colonial Road, Manchester, Connecticut | 06040 | |
| (Address of principal executive offices) | (zip code) |
Registrant’s telephone number, including area code: (860) 646-1233
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
LYDALL, INC.
| Page Number | ||||
| Item 2.02 |
Results of Operations and Financial Condition | 3 | ||
| Item 9.01 |
Financial Statements and Exhibits | 3 | ||
| Signature | 4 | |||
| Exhibit Index | 5 | |||
2
Section 2 – Financial Information
Item 2.02 Results of Operations and Financial Condition
On February 21, 2005, Lydall, Inc. (the “Company”) issued a press release disclosing that its Charter Medical, Ltd. subsidiary announced a product recall of certain of its blood transfer and storage products and the estimated financial and future business impact of this recall. A copy of the Company’s press release is furnished as Exhibit 99.1 and is hereby incorporated by reference.
Section 9 – Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits
(c) Exhibits
The following is furnished as an Exhibit to this report:
| Exhibit Number |
Description of Exhibit | |
| 99.1 | Press Release dated February 21, 2005, “Charter Medical, Ltd., a Subsidiary of Lydall, Inc., Announces a Voluntary Product Recall.” |
3
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| LYDALL, INC. | ||||
| February 22, 2005 | By: | /S/ JOHN J. KRAWCZYNSKI | ||
| John J. Krawczynski Controller (On behalf of the Registrant and as Principal Accounting Officer) | ||||
4
LYDALL, INC.
| Exhibit Number |
||
| 99.1 | Press Release dated February 21, 2005, titled “Charter Medical, Ltd., a Subsidiary of Lydall, Inc., Announces a Voluntary Product Recall,” filed herewith. |
5